DelMar's abstract "VAL083, a novel N7 alkylating agent, surpasses temozolomide activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme" at American Association of Cancer Research (AACR) Annual Meeting Apr 1, 2012
